Damora Therapeutics, Inc.
USD21.58
-0.75 (-3.36%)
CEO
Jennifer A. Jarrett
IPO Date
2020-10-28
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ
Country
US
Open
$22.26
Prev. Close
$22.33
Day Low
$21.58
Day High
$23.54
52W Low
$2.01
52W High
$38.33
Market Cap
$0.03B
Volume
0.00M
| 129,000 |
| $0.00 |
| 12 Feb 2026 | Fairmount Funds Management LLC | director, 10 percent owner: | M-Exempt | Disposed | 2,904 | $0.00 |
| 12 Feb 2026 | Fairmount Funds Management LLC | director, 10 percent owner: | M-Exempt | Acquired | 5,809,000 | $0.00 |
| 12 Feb 2026 | Fairmount Funds Management LLC | director, 10 percent owner: | M-Exempt | Acquired | 2,904,000 | $0.00 |
| 12 Feb 2026 | Fairmount Funds Management LLC | director, 10 percent owner: | M-Exempt | Disposed | 5,809 | $0.00 |
| 26 Jan 2026 | Sattarzadeh Sherwin | Chief Operating Officer | A-Award | Acquired | 190,376 | $0.00 |
| 26 Jan 2026 | Sattarzadeh Sherwin | Chief Operating Officer | A-Award | Acquired | 444,209 | $21.82 |
| 26 Jan 2026 | Sattarzadeh Sherwin | — | Disposed | 0 | $0.00 |
| 7 Jan 2026 | Hewes L. Becker | Chief Medical Officer | A-Award | Acquired | 264,629 | $0.00 |